Literature DB >> 20692659

The association of low selenium and renal insufficiency with coronary heart disease and all-cause mortality: NHANES III follow-up study.

Charles B Eaton1, Abdul Rahman Abdul Baki, Molly E Waring, Mary B Roberts, Bing Lu.   

Abstract

Although prospective studies suggest that low selenium is a risk factor for cardiovascular disease, most clinical trials of selenium supplementation have not shown this benefit. Prospective studies of renal insufficiency show that it is associated with low-selenium levels, and increased cardiovascular disease risk. We hypothesized that low selenium and renal insufficiency might show biologically important interactions warranting a future trial of selenium supplementation in this high-risk group of patients with both renal insufficiency and low selenium. We evaluated the prospective association of low selenium and renal insufficiency with coronary heart disease and all-cause mortality. A cohort of 10,531 NHANES III participants aged 35 years or older with serum selenium measurements and creatinine were followed longitudinally and linked to the National Death Index. In multivariable-adjusted analysis, low-selenium levels were associated with an increased risk of CHD mortality (HR=1.26; 95% CI: 0.94-1.69) and an increased risk for all-cause mortality (HR=1.41; 95% CI: 1.18-1.68). Renal insufficiency was also associated with increased risk of CHD mortality (HR=1.64; 95% CI: 1.29-2.08) and all-cause mortality (HR=1.51; 95% CI: 1.31-1.74). Despite the findings that adults with impaired renal function and low selenium had an increased risk for CHD mortality (HR=2.06; 95% CI: 1.13-3.75), there was no evidence of supra-additivity between low selenium and renal insufficiency on rate of CHD mortality (relative excess risk due to the interaction [RERI=0.16; 95% CI: -1.34 to 1.65] or all-cause mortality (RERI=-0.85; 95% CI: -1.50 to -0.20). This analysis suggests that the combination of renal insufficiency and low selenium does not represent an extremely high-risk group where a randomized trial of selenium supplementation would be of greater value than focusing on all adults with low-serum selenium.
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20692659     DOI: 10.1016/j.atherosclerosis.2010.07.008

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  8 in total

1.  Selenium status and cardiovascular diseases: meta-analysis of prospective observational studies and randomized controlled trials.

Authors:  X Zhang; C Liu; J Guo; Y Song
Journal:  Eur J Clin Nutr       Date:  2015-05-20       Impact factor: 4.016

2.  Inflammatory potential of diet and all-cause, cardiovascular, and cancer mortality in National Health and Nutrition Examination Survey III Study.

Authors:  Nitin Shivappa; Susan E Steck; James R Hussey; Yunsheng Ma; James R Hebert
Journal:  Eur J Nutr       Date:  2015-12-07       Impact factor: 5.614

3.  Levels of sP-selectin and hs-CRP Decrease with Dietary Intervention with Selenium and Coenzyme Q10 Combined: A Secondary Analysis of a Randomized Clinical Trial.

Authors:  Urban Alehagen; Tomas L Lindahl; Jan Aaseth; Erland Svensson; Peter Johansson
Journal:  PLoS One       Date:  2015-09-16       Impact factor: 3.240

Review 4.  Selenium and its supplementation in cardiovascular disease--what do we know?

Authors:  Carina Benstoem; Andreas Goetzenich; Sandra Kraemer; Sebastian Borosch; William Manzanares; Gil Hardy; Christian Stoppe
Journal:  Nutrients       Date:  2015-04-27       Impact factor: 5.717

Review 5.  Systematic review of zinc biochemical indicators and risk of coronary heart disease.

Authors:  Maryam Hashemian; Hossein Poustchi; Fatemeh Mohammadi-Nasrabadi; Azita Hekmatdoost
Journal:  ARYA Atheroscler       Date:  2015-11

Review 6.  Environmental heavy metals and cardiovascular diseases: Status and future direction.

Authors:  Ai-Min Yang; Kenneth Lo; Tong-Zhang Zheng; Jing-Li Yang; Ya-Na Bai; Ying-Qing Feng; Ning Cheng; Si-Min Liu
Journal:  Chronic Dis Transl Med       Date:  2020-04-03

7.  Increased hair selenium concentration in hyperlipidemic patients.

Authors:  Péter Fülöp; Ildikó Seres; Zoltán Jenei; Imre Juhász; György Paragh
Journal:  J Cell Mol Med       Date:  2013-02-13       Impact factor: 5.310

8.  Supplementation with Selenium and Coenzyme Q10 Reduces Cardiovascular Mortality in Elderly with Low Selenium Status. A Secondary Analysis of a Randomised Clinical Trial.

Authors:  Urban Alehagen; Jan Alexander; Jan Aaseth
Journal:  PLoS One       Date:  2016-07-01       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.